Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 22, Pages 8870
Publisher
MDPI AG
Online
2020-11-24
DOI
10.3390/ijms21228870
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain
- (2020) Stevie C. Britch et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
- (2020) Chris D. Verrico et al. PAIN
- Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination
- (2020) Katja Linher-Melville et al. PLoS One
- The Therapeutic Effectiveness of Full Spectrum Hemp Oil Using a Chronic Neuropathic Pain Model
- (2020) Jacob M. Vigil et al. Life-Basel
- Understanding the Medical Chemistry of the Cannabis Plant is Critical to Guiding Real World Clinical Evidence
- (2020) Karim S. Ladha et al. MOLECULES
- Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
- (2020) Torsten Lowin et al. Cell Death & Disease
- Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
- (2019) Linda C. Laux et al. EPILEPSY RESEARCH
- Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain
- (2019) Hayes Wong et al. ARCHIVES OF ORAL BIOLOGY
- Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors
- (2019) Carlos Henrique Alves Jesus et al. BRAIN RESEARCH
- Dose‐Dependent Cannabidiol‐Induced Elevation of Intracellular Calcium and Apoptosis in Human Articular Chondrocytes
- (2019) Martina Winklmayr et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study
- (2019) Alex Capano et al. POSTGRADUATE MEDICINE
- The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities
- (2019) Dixon H. Xu et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease
- (2019) Glauce Crivelaro do Nascimento et al. NEUROPHARMACOLOGY
- Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain
- (2019) Antony D. Abraham et al. NEUROPSYCHOPHARMACOLOGY
- GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol
- (2018) Alyssa S. Laun et al. ACTA PHARMACOLOGICA SINICA
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice
- (2018) Hongbo Li et al. CELLULAR IMMUNOLOGY
- Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
- (2018) Aron H. Lichtman et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Enhanced endocannabinoid tone as a potential target of pharmacotherapy
- (2018) Marek Toczek et al. LIFE SCIENCES
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay
- (2018) L. Cuñetti et al. TRANSPLANTATION PROCEEDINGS
- Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation
- (2018) Yue-min Bian et al. ACTA PHARMACOLOGICA SINICA
- Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
- (2018) Gemma Navarro et al. BIOCHEMICAL PHARMACOLOGY
- Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- (2018) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Inhibitory effects of cannabidiol on voltage-dependent sodium currents
- (2018) Mohammad-Reza Ghovanloo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain
- (2018) Danilo De Gregorio et al. PAIN
- Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain
- (2018) Erin M. Rock et al. PSYCHOPHARMACOLOGY
- Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol
- (2018) Nicholas Z. Greene et al. PSYCHOPHARMACOLOGY
- Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
- (2018) José A. Crippa et al. Frontiers in Immunology
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
- (2018) Tine van de Donk et al. PAIN
- Sativex® effects on promoter methylation and on CNR1 / CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients
- (2017) Massimo Santoro et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis
- (2017) Holly T. Philpott et al. PAIN
- Cannabis constituent synergy in a mouse neuropathic pain model
- (2017) Sherelle L. Casey et al. PAIN
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
- (2017) T. Bakas et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
- (2017) Karina Genaro et al. Frontiers in Pharmacology
- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein
- (2016) Huan Huang et al. BIOCHEMISTRY
- Evaluating Sativex®in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis
- (2016) Margherita Russo et al. PAIN MEDICINE
- Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice
- (2016) Hannah Harris et al. PLANTA MEDICA
- Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice
- (2015) Harshini Neelakantan et al. BEHAVIOURAL PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
- (2015) D.C. Hammell et al. EUROPEAN JOURNAL OF PAIN
- Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
- (2015) Alex F. Manini et al. Journal of Addiction Medicine
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Critical Role of Mast Cells and Peroxisome Proliferator–Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo
- (2015) Venkatesh L. Hegde et al. JOURNAL OF IMMUNOLOGY
- The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors
- (2015) Miguel Moreno-Martet et al. Multiple Sclerosis and Related Disorders
- A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
- (2014) M. Serpell et al. EUROPEAN JOURNAL OF PAIN
- A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain
- (2014) B. Hoggart et al. JOURNAL OF NEUROLOGY
- Cannabidiol and endogenous opioid peptide-mediated mechanisms modulate antinociception induced by transcutaneous electrostimulation of the peripheral nervous system
- (2014) Thais Cristina Teixeira Gonçalves et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats
- (2014) Stephanie Mijangos-Moreno et al. NEUROSCIENCE RESEARCH
- Cannabinoid-induced changes in respiration of brain mitochondria
- (2014) Zdeněk Fišar et al. TOXICOLOGY LETTERS
- Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1Areceptors without diminishing nervous system function or chemotherapy efficacy
- (2013) Sara Jane Ward et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors
- (2013) Mohamed Mahgoub et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain
- (2013) Mary E. Lynch et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
- (2013) Ana Juknat et al. PLoS One
- Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
- (2013) N Rimmerman et al. Cell Death & Disease
- Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
- (2012) Massimo Nabissi et al. CARCINOGENESIS
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
- (2012) Wei Xiong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
- (2012) Peer W. F. Karmaus et al. Journal of Immunotoxicology
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
- (2012) Russell K. Portenoy et al. JOURNAL OF PAIN
- An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
- (2012) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice
- (2011) Sara Jane Ward et al. ANESTHESIA AND ANALGESIA
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
- (2010) Sabatino Maione et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes
- (2010) K. H. Yang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cannabinoid-Mediated Modulation of Neuropathic Pain and Microglial Accumulation in a Model of Murine Type I Diabetic Peripheral Neuropathic Pain
- (2010) Cory C Toth et al. Molecular Pain
- Cannabidiol-2',6'-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-Lipoxygenase Inhibitor
- (2009) S. Takeda et al. DRUG METABOLISM AND DISPOSITION
- Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
- (2009) Ankur Kapur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Δ9-Tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro
- (2009) Marcel Jenny et al. JOURNAL OF NEUROIMMUNOLOGY
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
- (2009) Jeremy R. Johnson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function
- (2009) Jörg Ahrens et al. PHARMACOLOGY
- The GPR55 ligand l-α-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
- (2008) Christopher M. Henstridge et al. FASEB JOURNAL
- Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
- (2008) Hamish Redmond Ross et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons
- (2008) N. Qin et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death
- (2008) H. Pan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8
- (2008) L. De Petrocellis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now